Bank of New York Mellon’s Avadel Pharmaceuticals AVDL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.23M | Buy |
251,839
+17,719
| +8% | +$157K | ﹤0.01% | 2685 |
|
|
2025
Q1 | $1.83M | Buy |
234,120
+9,025
| +4% | +$70.7K | ﹤0.01% | 2729 |
|
|
2024
Q4 | $2.37M | Sell |
225,095
-971
| -0.4% | -$10.2K | ﹤0.01% | 2680 |
|
|
2024
Q3 | $2.96M | Sell |
226,066
-99,322
| -31% | -$1.3M | ﹤0.01% | 2561 |
|
|
2024
Q2 | $4.57M | Buy |
+325,388
| New | +$4.57M | ﹤0.01% | 2384 |
|
|
2017
Q2 | – | Sell |
-1,776,969
| Closed | -$17.2M | – | 4297 |
|
|
2017
Q1 | $17.2M | Sell |
1,776,969
-6,142
| -0.3% | -$59.5K | ﹤0.01% | 1635 |
|
|
2016
Q4 | $18.5M | Buy |
1,783,111
+7,524
| +0.4% | +$78.2K | 0.01% | 1581 |
|
|
2016
Q3 | $22M | Sell |
1,775,587
-42,992
| -2% | -$533K | 0.01% | 1403 |
|
|
2016
Q2 | $19.5M | Sell |
1,818,579
-1,923,365
| -51% | -$20.7M | 0.01% | 1417 |
|
|
2016
Q1 | $41.3M | Buy |
3,741,944
+1,122,072
| +43% | +$12.4M | 0.01% | 977 |
|
|
2015
Q4 | $32M | Buy |
2,619,872
+820,691
| +46% | +$10M | 0.01% | 1083 |
|
|
2015
Q3 | $29.3M | Sell |
1,799,181
-89,419
| -5% | -$1.46M | 0.01% | 1163 |
|
|
2015
Q2 | $40M | Buy |
1,888,600
+553,825
| +41% | +$11.7M | 0.01% | 1034 |
|
|
2015
Q1 | $24M | Buy |
1,334,775
+1,162,189
| +673% | +$20.9M | 0.01% | 1363 |
|
|
2014
Q4 | $2.96M | Sell |
172,586
-34,733
| -17% | -$595K | ﹤0.01% | 2603 |
|
|
2014
Q3 | $2.97M | Sell |
207,319
-83,560
| -29% | -$1.2M | ﹤0.01% | 2614 |
|
|
2014
Q2 | $4.36M | Sell |
290,879
-58,650
| -17% | -$880K | ﹤0.01% | 2401 |
|
|
2014
Q1 | $4.68M | Buy |
349,529
+52,876
| +18% | +$709K | ﹤0.01% | 2342 |
|
|
2013
Q4 | $2.39M | Buy |
296,653
+46,728
| +19% | +$376K | ﹤0.01% | 2780 |
|
|
2013
Q3 | $1.64M | Buy |
249,925
+24,488
| +11% | +$161K | ﹤0.01% | 2973 |
|
|
2013
Q2 | $1.38M | Buy |
+225,437
| New | +$1.38M | ﹤0.01% | 2994 |
|